Yahoo Web Search

Search results

1. • Santa J. Ono, University of Michigan President, Joins USJF Board

     Wisconsin State Journal· 3 days ago

     Santa J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...

2. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 5 days ago

     Webinar, moderated by Cantor Fitzgerald, will be held on Monday, May 13, 2024, at 2:00 p.m. ET Discussion will feature Dr. Michel Michaelides, leading expert in the field of inherited eye disease in adults and children SAN DIEGO, May 06

3. • Santa J. Ono, University of Michigan President, Joins USJF Board

     The Longview News-Journal· 3 days ago

     Santa J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...

4. • Here are practical strategies to help seniors manage their health challenges

     Fontana Herald News· 1 day ago

     Older adults often face multiple issues that can impact their quality of life. Let's explore 12 common health challenges in senior adults and practical strategies to tackle them. 1. Arthritis ...

5. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 2 days ago

     Wilmington, Delaware, May 08, 2024 (GLOBE NEWSWIRE) -- Ophthalmic operating tables market is witnessing significant growth, owing to the rising prevalence of ophthalmic surgeries globally. With an increasing aging population and the prevalence

6. • 

     Santa J. Ono, University of Michigan President, Joins USJF Board

     The Journal Times· 3 days ago

     Santa J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation...

7. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 4 days ago

     Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA

8. • 

     ASGCT: Ring's 'new class of viral vector' is re-dosable in primates, overcoming key challenge of...

     FierceBiotech· 2 days ago

     Pandemic aside, things were going well for Tuyen Ong, M.D. The physician and biotech entrepreneur...

9. • 

     Baby Boomers' 14 Least Favorite Drug Brands: Ranked

     247wallst.com· 3 days ago

     Baby boomers are currently one of the oldest demographics. For this reason, they’re also some of the most familiar with medications. But with so many...

10. • Brokers Offer Predictions for Apellis Pharmaceuticals, Inc.’s FY2026 Earnings (NASDAQ:APLS)

      ETF DAILY NEWS· 21 hours ago

      Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at Wedbush lowered their FY2026 earnings estimates for shares of Apellis Pharmaceuticals in a report released on Tuesday, ...